Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,291 | 20,250 | 39,490 | 10,572 | 15,217 |
| Marketable Securities | 249 | 1,494 | 2,490 | 2,269 | 1,992 |
| Receivables | 1,328 | 196 | 197 | 604 | 1,341 |
| Other current assets | 329 | 542 | 202 | 238 | 238 |
| TOTAL | $63,970 | $23,389 | $42,788 | $14,642 | $18,898 |
| Non-Current Assets | |||||
| PPE Net | 6,587 | 6,040 | 5,591 | 5,436 | 2,919 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 850 |
| TOTAL | $6,587 | $6,040 | $5,591 | $5,436 | $3,769 |
| Total Assets | $70,557 | $29,429 | $48,379 | $20,078 | $22,667 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 154 | 149 | 6,093 | 91 | N/A |
| Accounts payable and accrued liabilities | 612 | 972 | 1,670 | 552 | 1,080 |
| Accrued Expenses | 2,861 | 1,659 | 1,867 | 1,554 | 1,176 |
| Other current liabilities | N/A | N/A | N/A | 1 | 3 |
| TOTAL | $3,876 | $2,919 | $10,664 | $3,265 | $3,241 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,033 | 1,140 | 848 | 6,942 | 6,000 |
| Deferred Revenues | 84 | 84 | 913 | 951 | 947 |
| Other Non-Current Liabilities | 6,000 | 6,000 | -1 | 62,094 | 54,367 |
| TOTAL | $8,354 | $8,583 | $942 | $68,832 | $60,212 |
| Total Liabilities | $12,230 | $11,502 | $11,606 | $72,097 | $63,453 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,095 | 2,844 | 2,296 | N/A | N/A |
| Common Shares | 266 | 210 | 206 | 36 | 67 |
| Retained earnings | -135,977 | -104,797 | -81,476 | -63,389 | -47,176 |
| Other shareholders' equity | 0 | 0 | 0 | 2,930 | 2,314 |
| TOTAL | $58,327 | $17,927 | $36,773 | $-52,019 | $-40,786 |
| Total Liabilities And Equity | $70,557 | $29,429 | $48,379 | $20,078 | $22,667 |